LAUSR

Base Study: concepts and preliminary baseline descriptive statistics. Urology 1997; 49: 64–75. 63 Wennevik G, Meijlink J, Hanno P, Nordling J. The Role of Glomerulations in Bladder Pain Syndrome: a Review. J. Urol. 2016; 195: 19–25. 64 Greenberg E, Barnes R, Stewart S, Furnish T. Transurethral resection of Hunner’s ulcers. J. Urol. 1974; 111: 764–6. 65 Payne RA, O’Connor RC, Kressin M, Guralnick ML. Endoscopic ablation of hunner’s lesions in interstitial cystitis patients. Can. Urol. Assoc. J. 2009; 3: 473–7. 66 Rossberger J, Fall M, Jonsson O, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology 2007; 70: 638–42. 67 Peters K, Jaeger C, Killinger K, Rosenberg B, Boura J. Cystectomy for ulcerative interstitial cystitis: sequelae and patients’ perceptions of improvement. Urology 2013; 82: 829–33. 68 Swamy S, Barcella DeIorio M, Gill K et al. Recalcitrant chronic bladder pain and recurrent cystitis but negative urinalysis: What should we do? Int. Urogynecol. J. 2018; 29: 1035–43. 69 Quaghebeur J, Wyndaele JJ, DeWatcher S. Pain areas and mechanosensitivity in patients with chronic pelvic pain syndrome: a controlled clinical investigation. Scand. J. Urol. 2017; 51: 414–9. 70 Aldenborg F, Fall M, Enerb€ack L. Proliferation and transepithelial migration of mucosal mast cells in interstitial cystitis. Immunology 1986; 58: 411–6. 71 Larsen M, Mortensen S, Nordling J, Horn T. Quantifying mast cells in bladder pain syndrome by immunohistochemical anzalysis. BJU Int. 2008; 102: 204–7. 72 Theoharides T, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 2007; 217: 65–78. 73 Peeker R, Aldenborg F, Fall M. Nephrogenic adenoma – a study with special reference to clinical presentation. Br. J. Urol. 1997; 80: 539–42.